Literature DB >> 6611371

Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes.

C A Dinarello, G H Clowes, A H Gordon, C A Saravis, S M Wolff.   

Abstract

Interleukin 1 (IL 1) is a product(s) of mononuclear phagocytes, and has multiple biologic activities that mediate several host responses to infection and inflammation. Highly purified IL 1 activates lymphocytes, induces fever, increases hepatic acute phase protein synthesis, and increases muscle protein degradation. A 4.2 kd peptide has been purified from plasma of febrile humans which also induces muscle proteolysis in vitro (termed proteolysis-inducing factor, PIF). Because IL 1 purified from activated human monocytes induces muscle proteolysis in vitro, studies were performed to determine the relationship of human monocyte-derived IL 1 to plasma-derived PIF. Purified PIF was highly active in the IL 1 thymocyte assay. After gel filtration of plasma from febrile patients, fractions with PIF activity also induced thymocyte proliferation and fever in mice. Thus, it seems likely that the plasma peptide PIF has IL 1 properties and probably represents a small m.w. cleavage product of IL 1. Further studies confirmed this finding. Highly purified 15 kd IL 1, rechromatographed over different gel filtration media, consistently fragmented into a 4 kd peptide with both muscle proteolysis-inducing and lymphocyte-activating properties. The breakdown of the 15 kd IL 1 into biologically active smaller fragments increased with time, and could be accelerated by trypsinization. The monocyte-derived IL 1 fragments were partially destroyed by heat. Highly purified 125I-labeled 15 kd IL 1 also fragmented into subunits, and these radioactive subunits produced fever in mice and were active in the thymocyte assay. Fragmentation of 125I-labeled 15 kd IL 1 was reduced by agents that inhibit proteases. These results indicate that some of the biologic activities of human IL 1 are conserved in small m.w. fragments. These studies also provide evidence that IL 1 may circulate in humans as a 4.2 kd peptide, and that this cleavage product can function as an active mediator of IL 1 effects in the host.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611371

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Invertebrate cytokines: tunicate cell proliferation stimulated by an interleukin 1-like molecule.

Authors:  D A Raftos; E L Cooper; G S Habicht; G Beck
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses.

Authors:  S K Sundar; K J Becker; M A Cierpial; M D Carpenter; L A Rankin; S L Fleener; J C Ritchie; P E Simson; J M Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.

Authors:  C Drouet; A Reboul; M Colomb
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Expression of biologically active human interleukin 1 subpeptides by transfected simian COS cells.

Authors:  L J Rosenwasser; A C Webb; B D Clark; S Irie; L Chang; C A Dinarello; L Gehrke; S M Wolff; A Rich; P E Auron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 5.  The molecular forms of interleukin-1.

Authors:  T P Hopp; S K Dower; C J March
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

6.  Proliferative signals for suppressor T cells. Helper cells stimulated with pokeweed mitogen in vitro produce a suppressor cell growth factor.

Authors:  E J Fox; R G Cook; D E Lewis; R R Rich
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 7.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

8.  Antibodies of predetermined specificity to the major charged species of human interleukin 1.

Authors:  G Limjuco; S Galuska; J Chin; P Cameron; J Boger; J A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 9.  An update on human interleukin-1: from molecular biology to clinical relevance.

Authors:  C A Dinarello
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

Review 10.  Cytokines regulating acute inflammation and synthesis of acute phase proteins.

Authors:  A Koj
Journal:  Blut       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.